Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

Les informations sur les projets et maintenant aussi les résumés de rapports Horizon 2020 sont disponibles sur CORDIS. Tous les projets H2020 peuvent être téléchargés depuis le Portail des données ouvertes de l'UE .

My refinements


Download results of this page


Affiner par:

Sujet

Agriculture (1240)
Alimentation (745)
Applications dans le domaine des technologies de l'information (299)
Aspects commerciaux (63)
Aspects économiques (2519)
Automatisation (8)
Autres technologies (100)
Autres thèmes liés à l'énergie (140)
Biocarburants (40)
Biotechnologie (1673)
Biotechnologie agricole (157)
Biotechnologie industrielle (12)
Biotechnologie médicale (275)
Combustibles fossiles (31)
Conservation de l'énergie et transport de l'énergie (150)
Considérations d¿emploi (576)
Coordination et coopération (1338)
Droits de propriété intellectuelle (1)
Déchets radioactifs (34)
Développement durable (99)
Développement régional (349)
Economie d'énergie (807)
Education et formation (1719)
Electronique et microélectronique (1050)
Evaluation (100)
Fabrication industrielle (2334)
Fission nucléaire (264)
Fusion nucléaire (79)
Gestion des déchets (354)
Hydrogène et piles à combustible (34)
Information et médias (729)
Innovation et Transfert de technologies (1928)
Législation et règlements (100)
Mathématiques et statistique (79)
Matériaux de référence (231)
Médecine et santé (2825)
Méthodes de mesures (285)
Météorologie (555)
Nanotechnologie et nanosciences (280)
Normalisation (243)
Prestations/services de soins de santé (150)
Protection de l'environnement (3492)
Prévisions (357)
Radioprotection (124)
Recherche scientifique (6208)
Recherche spatiale et par satellite (120)
Recherche sur les changements climatiques et le cycle du carbone (60)
Ressources de la mer et pêche (813)
Ressources en eau et gestion (73)
Robotique (20)
Sciences de la terre (360)
Sciences du vivant (3540)
Sciences physiques et ingénierie (308)
Sciences sociales et humaines (2931)
Sciences vétérinaires et des animaux (30)
Sources d'énergie renouvelables (475)
Stratégies (685)
Sécurité (1751)
Technologie aérospatiale (392)
Technologie de la construction (111)
Technologie des matériaux (850)
Technologies de charbon propre (1)
Technologies de réseaux (433)
Traitement de l'information et systèmes d'information (2183)
Transports (1291)
Télécommunications (1241)
Éthique de la recherche (68)

Programme

Autres
Tous
CIP (135)
EAEC-FUSION 12C (1)
EAEC-NFS 2 (45)
ECSC-COAL-STEEL-RTD C (37)
ECSC-COALRES 7C (5)
ECSC-ERGONOM 5C (6)
ECSC-ERGONOM 6C (4)
ECSC-MEDRES 5C (7)
ECSC-MINEHYG 6C (1)
ECSC-STEEL C (69)
ECSC-STEELDEM 1C (3)
ECSC-STEELDEM 2C (2)
ECSC-STEELDEM 3C (11)
ECSC-STEELRES 6C (7)
ECSC-STEELRES 7C (25)
ECSC-STEELRES 8C (62)
ECSC-WORKENV 5C (4)
ECSC-WORKSAFE C (2)
ENG-ALTENER 1 (9)
ENG-ALTENER 2 (25)
ENG-ENALT 1C (21)
ENG-ENALT 2C (25)
ENG-ENDEMO C (70)
ENG-HYDROCARB 1C (25)
ENG-HYDROCARB 2C (11)
ENG-SAVE 1 (25)
ENG-SAVE 2 (18)
ENG-THERMIE 1 (56)
ENV-ACE 2 (3)
ENV-LIFE 1 (15)
ENV-LIFE 2 (17)
ET-COMETT 1 (28)
ET-COMETT 2 (6)
ET-EUROTECNET 2 (58)
ET-LEONARDO DA VINCI 1 (370)
ET-PETRA 1 (16)
FP1-AGRIRES 3C (9)
FP1-BAP (78)
FP1-BRITE (46)
FP1-CLIMAT 3C (10)
FP1-DECOM 2C (1)
FP1-ENNONUC 3C (94)
FP1-ENVPROT 4C (25)
FP1-ESPRIT 1 (49)
FP1-EURAM (12)
FP1-RADPROT 6C (35)
FP1-RADWASTOM 3C (9)
FP1-RAWMAT 3C (34)
FP1-STIMULATION 1C (47)
FP1-TECHHAZ C (3)
FP2-AERO 0C (17)
FP2-AIM 1 (21)
FP2-BCR 4 (176)
FP2-BRIDGE (41)
FP2-BRITE/EURAM 1 (91)
FP2-CAMAR (22)
FP2-DECOM 3C (5)
FP2-DELTA 1 (10)
FP2-DOSES (3)
FP2-DRIVE 1 (24)
FP2-ECLAIR (11)
FP2-EPOCH (11)
FP2-ESPRIT 2 (152)
FP2-EURET (5)
FP2-FAR (26)
FP2-FAST 3 (6)
FP2-FLAIR (12)
FP2-FOREST (8)
FP2-HUMGEN C (4)
FP2-JOULE 1 (69)
FP2-MAST 1 (19)
FP2-MATREC C (6)
FP2-MHR 4C (45)
FP2-MONITOR (1)
FP2-RACE 1 (35)
FP2-RADPROT 7C (21)
FP2-RADWASTOM 4C (10)
FP2-REWARD (6)
FP2-SCIENCE (114)
FP2-SCIFAC C (3)
FP2-SPES (20)
FP2-STD 2 (32)
FP2-STEP (41)
FP2-TELEMAN (4)
FP3-AERO 1C (19)
FP3-AIM 2 (24)
FP3-AIR (206)
FP3-BIOMED 1 (41)
FP3-BIOTECH 1 (69)
FP3-BRITE/EURAM 2 (110)
FP3-CRAFT (52)
FP3-DELTA 2 (3)
FP3-DRIVE 2 (35)
FP3-ENS (9)
FP3-ENV 1C (219)
FP3-ESPRIT 3 (174)
FP3-ESSI 1 (10)
FP3-HCM (302)
FP3-JOULE 2 (150)
FP3-LIBRARIES (24)
FP3-LRE (13)
FP3-MAST 2 (33)
FP3-MAT (58)
FP3-NFS 1 (28)
FP3-ORA (3)
FP3-RACE 2 (47)
FP3-RENA (9)
FP3-STD 3 (81)
FP3-TELMATPREP C (17)
FP4-ACTS (65)
FP4-BIOMED 2 (190)
FP4-BIOTECH 2 (207)
FP4-BRITE/EURAM 3 (713)
FP4-ENV 2C (329)
FP4-ESPRIT 4 (305)
FP4-ESSI 2 (14)
FP4-FAIR (336)
FP4-INCO (184)
FP4-INNOVATION (41)
FP4-MAST 3 (74)
FP4-NNE-JOULE C (217)
FP4-NNE-THERMIE C (33)
FP4-SMT (146)
FP4-TELEMATICS 2C (242)
FP4-TMR (435)
FP4-TRANSPORT (174)
FP4-TSER (95)
H2020-EU.1.1.
H2020-EU.1.2.
H2020-EU.1.2.1.
H2020-EU.1.2.2.
H2020-EU.1.2.3.
H2020-EU.1.3.1.
H2020-EU.1.3.2.
H2020-EU.1.3.3.
H2020-EU.1.3.4.
H2020-EU.1.3.5.
H2020-EU.1.4.
H2020-EU.1.4.1.1.
H2020-EU.1.4.1.2.
H2020-EU.1.4.1.3.
H2020-EU.1.4.2.2.
H2020-EU.1.4.3.
H2020-EU.1.4.3.1.
H2020-EU.1.4.3.2.
H2020-EU.2.
H2020-EU.2.1.1.
H2020-EU.2.1.1.1.
H2020-EU.2.1.1.3.
H2020-EU.2.1.1.4.
H2020-EU.2.1.1.5.
H2020-EU.2.1.1.6.
H2020-EU.2.1.1.7.
H2020-EU.2.1.2.
H2020-EU.2.1.2.1.
H2020-EU.2.1.2.2.
H2020-EU.2.1.2.3.
H2020-EU.2.1.2.4.
H2020-EU.2.1.2.5.
H2020-EU.2.1.3.
H2020-EU.2.1.3.1.
H2020-EU.2.1.3.4.
H2020-EU.2.1.3.5.
H2020-EU.2.1.3.7.
H2020-EU.2.1.4.
H2020-EU.2.1.5.
H2020-EU.2.1.5.1.
H2020-EU.2.1.5.2.
H2020-EU.2.1.5.3.
H2020-EU.2.1.5.4.
H2020-EU.2.1.6.
H2020-EU.2.1.6.1.
H2020-EU.2.1.6.1.1.
H2020-EU.2.1.6.1.2.
H2020-EU.2.1.6.2.
H2020-EU.2.1.6.3.
H2020-EU.2.2.
H2020-EU.2.3.
H2020-EU.2.3.1.
H2020-EU.2.3.2.
H2020-EU.2.3.2.2.
H2020-EU.2.3.2.3.
H2020-EU.3.
H2020-EU.3.1.
H2020-EU.3.1.1.
H2020-EU.3.1.2.
H2020-EU.3.1.3.
H2020-EU.3.1.4.
H2020-EU.3.1.5.
H2020-EU.3.1.6.
H2020-EU.3.1.7.
H2020-EU.3.1.7.12.
H2020-EU.3.1.7.13.
H2020-EU.3.1.7.4.
H2020-EU.3.1.7.6.
H2020-EU.3.2.
H2020-EU.3.2.1.
H2020-EU.3.2.1.1.
H2020-EU.3.2.1.2.
H2020-EU.3.2.1.3.
H2020-EU.3.2.2.
H2020-EU.3.2.2.3.
H2020-EU.3.2.3.
H2020-EU.3.2.4.
H2020-EU.3.2.4.1.
H2020-EU.3.2.5.
H2020-EU.3.2.6.
H2020-EU.3.3.
H2020-EU.3.3.1.
H2020-EU.3.3.1.3.
H2020-EU.3.3.2.
H2020-EU.3.3.2.1.
H2020-EU.3.3.2.2.
H2020-EU.3.3.2.3.
H2020-EU.3.3.2.4.
H2020-EU.3.3.3.
H2020-EU.3.3.3.1.
H2020-EU.3.3.3.2.
H2020-EU.3.3.3.3.
H2020-EU.3.3.4.
H2020-EU.3.3.5.
H2020-EU.3.3.6.
H2020-EU.3.3.7.
H2020-EU.3.3.8.1.
H2020-EU.3.3.8.2.
H2020-EU.3.3.8.3.
H2020-EU.3.4.
H2020-EU.3.4.5.1.
H2020-EU.3.4.5.2.
H2020-EU.3.4.5.3.
H2020-EU.3.4.5.4.
H2020-EU.3.4.5.5.
H2020-EU.3.4.5.6.
H2020-EU.3.4.6.1.
H2020-EU.3.4.7.
H2020-EU.3.4.7.1
H2020-EU.3.5.
H2020-EU.3.5.1.
H2020-EU.3.5.1.2.
H2020-EU.3.5.1.3.
H2020-EU.3.5.2.
H2020-EU.3.5.2.2.
H2020-EU.3.5.2.3.
H2020-EU.3.5.3.
H2020-EU.3.5.3.2.
H2020-EU.3.5.4.
H2020-EU.3.5.4.2.
H2020-EU.3.5.5.
H2020-EU.3.6.
H2020-EU.3.6.1.1.
H2020-EU.3.6.1.2.
H2020-EU.3.6.1.4.
H2020-EU.3.6.2.
H2020-EU.3.6.2.2.
H2020-EU.3.6.3.
H2020-EU.3.6.3.1.
H2020-EU.3.7.
H2020-EU.3.7.1.
H2020-EU.3.7.3.
H2020-EU.3.7.4.
H2020-EU.3.7.6.
H2020-EU.3.7.7.
H2020-EU.4.
H2020-EU.4.a.
H2020-EU.4.b.
H2020-EU.5.a.
H2020-EU.5.b.
H2020-EU.5.c.
H2020-EU.5.e.
H2020-EU.5.f.
H2020-Euratom
H2020-Euratom-1.1.
H2020-Euratom-1.2.
H2020-Euratom-1.3.
H2020-Euratom-1.4.
H2020-Euratom-1.8.
HS-TIDE 0 (12)
HS-TIDE 1 (19)
IC-AVICENNE (6)
IC-COST (58)
IC-COSU C (13)
IC-EUREKA (6)
IC-INTAS (473)
IC-ISC C (53)
IC-PECO/COPERNICUS (129)
IS-ECONTENT (27)
IS-IMPACT 1 (5)
IS-IMPACT 2 (33)
IS-INFO2000 (16)
IS-MLIS (2)
IS-SPRINT 1 (34)
IS-TEDIS 1 (3)
JRC-ADVMAT 1C (6)
JRC-ADVMAT 2C (4)
JRC-EXPLORES 1C (1)
JRC-EXPLORES 2C (2)
JRC-REACTSAFE 5C (1)
NAT-GR-OP-COM-PROD (6)
PRE-BEP (13)
PRE-CLIMAT 2C (6)
PRE-ENNONUC 2C (10)
PRE-ENVPROT 3C (27)
PRE-FAST 2 (7)
PRE-MAP (4)
PRE-MELREG C (6)
PRE-MHR 3C (9)
PRE-NUSAFECS C (9)
PRE-RADPROT 5C (28)
PRE-RADWASTOM 2C (6)
PRE-RAWMAT 2C (73)
PRE-STD 1 (24)
PRE-TEXTILE 2C (3)
REG-STRIDE (5)

Type de contenu

Projet (21969)
Résultat en bref (6513)
Résumé de rapport (2794)

Advanced search

Rechercher des projets et résultats

Results 1 - 10 of 31276
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Early stage CARdio Vascular Disease Detection with Integrated Silicon Photonics
ID: 644798
Date de début: 2015-02-01, Date de fin: 2018-07-31
Early identification of individuals at risk for CVD allows early intervention to halt or reverse the pathological process. This is the driver of Medtronic and partners to develop a mobile, low-cost, non-invasive, point-of-care screening device for CVD.Assessment of arterial...
Programme: H2020-EU.2.1.1.6.
Record Number: 194245
Last updated on: 2017-02-14
Methodology for fast and reliable investigation and characterization of contaminated sites
ID: 711164
Date de début: 2015-12-01, Date de fin: 2016-05-31
The consortium (formed by 3 SMEs: Biorem, DGE and SSD) aims to deliver into market a technology for on-site and realtimesite investigation through high-performance probes, comprising sonic drilling combined with patented geo-radartechnology (GPR), chemometry data analysis and...
Programme: H2020-EU.3.5.
Record Number: 199434
Last updated on: 2015-12-14
Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates  humans
ID: 666092
Date de début: 2014-11-01, Date de fin: 2017-10-31
The ongoing Ebola outbreak in West Africa is the largest and deadliest the world has ever seen. In September 2014, the number of EBOV cases exceeded the total of all cases from previous known outbreaks. Further, this public health crisis shifted into a complex emergency, with...
Programme: H2020-EU.3.1.
Record Number: 196376
Last updated on: 2017-03-07
Do Cardiac Health: Advanced New Generation Ecosystem
ID: 643735
Date de début: 2015-02-01, Date de fin: 2018-01-31
The primary objective of Do CHANGE is to develop a health ecosystem for integrated disease management of citizens with high blood pressure and patients with ischemic heart disease or heart failure. The system will give them access to a set of personalized health services in a...
Programme: H2020-EU.3.1.
Record Number: 194096
Last updated on: 2016-10-27
Personalised Airport Systems for Seamless Mobility and Experience
ID: 636308
Date de début: 2015-06-01, Date de fin: 2018-05-31
PASSME aims to deliver industry-driven, passenger-centric novel solutions (up to TRL6) for passengers, airports and airlines to address the anticipated increase in demand for commercial flights in Europe by 2050. The goal is to reduce travel time by at least 60 minutes by...
Programme: H2020-EU.3.4.
Record Number: 193396
Last updated on: 2016-10-17
GLOBAL VALUE - Assessing the Impacts of Multinational Corporations  on GLOBAL Development and VALUE Creation
ID: 613295
Date de début: 2014-01-01, Date de fin: 2017-06-30
"The GLOBAL VALUE project develops an innovative framework for assessing impacts of Multinational Corporations (MNCs) on issues related to the Millennium Declaration, sustainable development, human rights, transparency, and anti-corruption. To ensure utility, we will monitor ...
Programme: FP7-SSH
Record Number: 111400
Last updated on: 2016-08-08
Xylella Fastidiosa Active Containment Through a multidisciplinary-Oriented Research Strategy
ID: 727987
Date de début: 2016-11-01, Date de fin: 2020-10-31
XF-ACTORS aims to establish a multidisciplinary research program to answer the urgent need to improve prevention, early detection and control of Xylella fastidiosa (Xf). Recently, Xf was introduced into Italy, where it is causing severe damage to olive crops, and in France...
Programme: H2020-EU.3.2.1.1.
Record Number: 206027
Last updated on: 2017-04-05
[RÉSUMÉ DE RAPPORT] Non-viral gene delivery
Non-viral therapy would in principle be preferable over viral therapy especially in underdeveloped countries simply because non-viral components are easier and cheaper to synthesize, store and transport. However they’re a number of problems with this approach, including ...
Programme: FP4-BIOMED 2
Record Number: 25938
Last updated on: 2001-03-05
ID: BMH4961279
Date de début: 1996-10-01, Date de fin: 1999-09-30
The long term correction of sickle cell anaemia and thalassaemia by gene therapy requires the stable integration of a fully functional a- or beta-globin gene into the genome of a sufficient number of bone marrow (stem) cells of the patient. To achieve this two major problems...
Programme: FP4-BIOMED 2
Record Number: 33908
Last updated on: 1996-10-21
OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly
ID: 634238
Date de début: 2015-05-01, Date de fin: 2020-04-30
Most older adults have multiple chronic diseases (multimorbidity) and multiple medications (polypharmacy).However, multimorbid patients are often excluded from clinical trials and most guidelines address diseases inisolation. Inappropriate drug prescription and poor drug...
Programme: H2020-EU.3.1.
Record Number: 193279
Last updated on: 2016-12-15
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-05-01